Cover Image
市場調查報告書

生醫光電(Biophotonics)的全球市場的預測 ∼2020年:醫療用途、非醫療用途

Biophotonics Market by Medical Applications (Bioimaging, Bioassays, Optical Biosensors and Biochips, Medical Devices), Non-Medical Applications (Biometric and Biosensing Devices, Uv Sterilization Equipment), and Regions - Global Forecast To 2020

出版商 MarketsandMarkets 商品編碼 345130
出版日期 內容資訊 英文 158 Pages
訂單完成後即時交付
價格
Back to Top
生醫光電(Biophotonics)的全球市場的預測 ∼2020年:醫療用途、非醫療用途 Biophotonics Market by Medical Applications (Bioimaging, Bioassays, Optical Biosensors and Biochips, Medical Devices), Non-Medical Applications (Biometric and Biosensing Devices, Uv Sterilization Equipment), and Regions - Global Forecast To 2020
出版日期: 2015年11月10日 內容資訊: 英文 158 Pages
簡介

全球生醫光電(Biophotonics)的市場預計從2015年到2020年以11.5%的年複合成長率發展,2020年達到501億8000萬美元的規模。該產業過去數年技術大幅度進步,加上奈米技術的崛起,家庭用POC設備的需求增加,人口的增加和文明病的擴大等要素,促進該市場的成長。

本報告提供全球生醫光電(Biophotonics)的市場相關調查、市場概要及結構、產業結構與價值鏈、對市場成長的各種影響因素及市場機會分析、醫療/非醫療的各種用途、地區/各主要國家的主要趨勢與市場規模的變化與預測、競爭環境、市場排行榜,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 各最終用途、地區市場
  • 地區概要
  • 各技術市場變化與預測
  • 透視影像用生醫光電(Biophotonics)的各地區市場

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各用途
    • 各技術
    • 各最終用途
    • 各地區
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 產業分析

  • 簡介
  • 價值鏈分析
  • 產業趨勢
  • 波特的五力分析
  • PEST分析

第7章 市場分析:各用途

  • 簡介
  • 透視影像
  • 內部影像 (內視鏡)
  • 分子頻譜
  • 表面影像
  • 顯微鏡
  • 光療法
  • 生物感應器
  • 其他

第8章 市場分析:各技術

  • 簡介
  • 體內
  • 體外

第9章 市場分析:各最終用途

  • 簡介
  • 醫療、診斷
  • 醫療、治療
  • 試驗零組件
  • 其他 (醫療之外)

第10章 地區分析

  • 簡介
  • 南北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區
    • 中東
    • 非洲

第11章 競爭環境

  • 概要
  • 市場排行榜分析
  • 競爭情形、趨勢
    • 新產品的投入
    • 協定、聯盟、契約、合作
    • 擴張、專利
    • 收購

第12章 企業簡介

  • 簡介
  • AFFYMETRIX, INC.
  • ANDOR TECHNOLOGY LTD
  • BECTON, DICKINSON AND COMPANY
  • CARL ZEISS AG
  • FEI COMPANY
  • HAMAMATSU PHOTONICS
  • LUMENIS LTD.
  • Olympus Corporation
  • PERKINELMER, INC.
  • ZECOTEK PHOTONICS INC.
    • 概要
    • 產品與服務
    • 財務趨勢
    • 主要策略
    • 近幾年的發展趨勢等

第13章 附錄

圖表

目錄
Product Code: SE 3889

Emergence of nanotechnology and significant technological advancements in the field of biophotonics are major market drivers

The global biophotonics market is expected to reach USD 50.18 billion by 2020, at a CAGR of 11.5% between 2015 and 2020. The biophotonics industry has witnessed tremendous technological improvements over the past few years. Major drivers identified for the growth of the biophotonics market are emergence of nanotechnology, significant technological advancements over the last few years, increase in the demand for home-based POC devices, and increasing population & growing lifestyle diseases. Major restraints are slow rate of commercialization, high cost involved in research and development, and reluctance toward the adoption of new treatment practices.

Surface imaging market is expected to grow at higher CAGR during the forecast period

The report provides a detailed segmentation of the biophotonics market based on various application areas which include see-through imaging, inside imaging, spectromolecular, surface imaging, microscopy, light therapy, biosensors, and others. The application in see-through imaging accounted for the largest market share of the total biophotonics market. However, the market for surface imaging t is expected to grow at the highest CAGR between 2015 and 2020.

Medical diagnostics has emerged as a largest market segment for biophotonics market in 2014

Based on the end use of the biophotonics technology, the market is segmented into medical diagnostics, medical therapeutics, tests & components, and other (non-medical) sectors. Medical diagnostics accounted for the largest share of in 2014. The biophotonics market in the following geographic regions has been included in the report - the Americas, Europe, Asia-Pacific, and Rest of the World (RoW). Out of these regions Americas market is expected to grow at a highest CAGR during the forecast period.

During this market study several interviews were conducted with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights. Break-up of profile of primary participants for the report is as given below:

  • By Company Type - Tier 1 - 35 %, Tier 2 - 40% and Tier 3 - 25%
  • By Designation - C level - 35%, Director level - 25%, Others - 40%
  • By Region - Americas - 43%, Europe - 19%, APAC - 29%, RoW - 9%

The report identifies market dynamics such as drivers, restraints, and opportunities. Apart from the market segmentation, the report also includes critical market data and quantitative information for each segment along with qualitative analyses such as the Porter's five forces analysis and value chain analysis. The report also discusses the future of the global market, supply chain, upcoming technologies, and applications with respect to biophotonics. Key players profiled in this report include Affymetrix, Inc. (U.S.), Andor Technology Ltd. (U.K.), Becton, Dickinson and Company (U.S.), Carl Zeiss AG (Germany), FEI Company (U.S.), Hamamatsu Photonics K.K. (Japan), Lumenis Ltd. (Israel), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), and Zecotek Photonics Inc. (Canada).

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATION
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key Industry Insights
      • 2.1.2.3. Breakdown of primary interviews
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Rapid growth in the elderly population
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Poor customer perception
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOPHOTONICS MARKET OVERVIEW
  • 4.2. BIOPHOTONICS MARKET, BY END-USE AND GEOGRAPHY
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE BIOPHOTONICS MARKET
  • 4.4. BIOPHOTONICS MARKET, BY TECHNOLOGY (2015-2020)
  • 4.5. SEE-THROUGH IMAGING BIOPHOTONICS MARKET, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BIOPHOTONICS MARKET, BY APPLICATION
    • 5.2.2. BIOPHOTONICS MARKET, TECHNOLOGY
    • 5.2.3. BIOPHOTONICS MARKET, BY END USE
    • 5.2.4. BIOPHOTONICS MARKET, BY GEOGRAPHY
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Emergence of Nanotechnology
      • 5.3.1.2. Significant technological advancements over the last few years
      • 5.3.1.3. Increase in the demand for home-based POC devices
      • 5.3.1.4. Aging population and growing lifestyle diseases
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Slow rate of commercialization
      • 5.3.2.2. High cost involved in research and development
      • 5.3.2.3. Reluctance toward the adoption of new treatment practices
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets in the developing countries
      • 5.3.3.2. The use of biophotonics in non-medical sectors
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Government regulations and long certification & approval cycles
      • 5.3.4.2. Pricing pressure in the point-of-care market

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. INDUSTRY TRENDS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. BARGAINING POWER OF SUPPLIERS
    • 6.4.2. BARGAINING POWER OF BUYERS
    • 6.4.3. THREAT OF NEW ENTRANTS
    • 6.4.4. THREAT OF SUBSTITUTES
    • 6.4.5. DEGREE OF COMPETITION
  • 6.5. PEST ANALYSIS
    • 6.5.1. POLITICAL FACTORS
    • 6.5.2. ECONOMIC FACTORS
    • 6.5.3. SOCIAL FACTORS
    • 6.5.4. TECHNOLOGICAL FACTORS

7. BIOPHOTONICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. SEE-THROUGH IMAGING
  • 7.3. INSIDE IMAGING (ENDOSCOPY)
  • 7.4. SPECTROMOLECULAR
  • 7.5. SURFACE IMAGING
  • 7.6. MICROSCOPY
  • 7.7. LIGHT THERAPY
  • 7.8. BIOSENSORS
  • 7.9. OTHERS

8. BIOPHOTONICS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. IN-VIVO
  • 8.3. IN-VITRO

9. BIOPHOTONICS MARKET, BY END USE

  • 9.1. INTRODUCTION
  • 9.2. MEDICAL DIAGNOSTICS
  • 9.3. MEDICAL THERAPEUTICS
  • 9.4. TEST COMPONENTS
  • 9.5. OTHER (NON-MEDICAL)

10. REGIONAL ANALYSIS

  • 10.1. INTRODUCTION
  • 10.2. AMERICAS
    • 10.2.1. U.S.
    • 10.2.2. CANADA
    • 10.2.3. MEXICO
    • 10.2.4. OTHERS
  • 10.3. EUROPE
    • 10.3.1. U.K.
    • 10.3.2. GERMANY
    • 10.3.3. FRANCE
    • 10.3.4. OTHERS
  • 10.4. APAC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. OTHERS
  • 10.5. ROW
    • 10.5.1. MIDDLE EAST
    • 10.5.2. AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. TOP 5 PLAYERS IN BIOPHOTONICS MARKET- MARKET RANKING
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES
    • 11.3.2. AGREEMENTS, COLLABORATIONS, CONTRACTS, & PARTNERSHIPS
    • 11.3.3. EXPANSIONS AND PATENTS
    • 11.3.4. ACQUISITIONS

12. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. INTRODUCTION
  • 12.2. AFFYMETRIX, INC.
  • 12.3. ANDOR TECHNOLOGY LTD
  • 12.4. BECTON, DICKINSON AND COMPANY
  • 12.5. CARL ZEISS AG
  • 12.6. FEI COMPANY
  • 12.7. HAMAMATSU PHOTONICS K.K.
  • 12.8. LUMENIS LTD.
  • 12.9. OLYMPUS CORPORATION
  • 12.10. PERKINELMER, INC.
  • 12.11. ZECOTEK PHOTONICS INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORT

LIST OF TABLES

  • TABLE 1: EMERGENCE OF NANOTECHNOLOGY AND TECHNOLOGICAL ADVANCEMENTS ARE THE KEY MARKET DRIVERS
  • TABLE 2: SLOW RATE OF COMMERCIALISATION AND HIGH COST OF R&D ARE MAJOR RESTRAINING FACTORS
  • TABLE 3: USE OF BIOPHOTONICS IN NON-MEDICAL APPLICATIONS IS A KEY OPPORTUNITY FOR THE COMPANIES
  • TABLE 4: GOVERNMENT REGULATIONS, LONG CERTIFICATION & APPROVAL CYCLES ARE THE MAJOR CHALLENGES FOR THE MARKET PLAYERS
  • TABLE 5: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 6: SEE-THROUGH IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
  • TABLE 7: INSIDE IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
  • TABLE 8: SPECTROMOLECULAR BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
  • TABLE 9: SURFACE IMAGING BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
  • TABLE 10: MICROSCOPY BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
  • TABLE 11: LIGHT THERAPY BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
  • TABLE 12: BIOSENSORS BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
  • TABLE 13: OTHER APPLICATIONS BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD MILLION)
  • TABLE 14: BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
  • TABLE 15: IN-VIVO BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
  • TABLE 16: IN-VITRO BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
  • TABLE 17: BIOPHOTONICS MARKET, BY END USE, 2013 - 2020 (USD BILLION)
  • TABLE 18: MEDICAL DIAGNOSTICS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
  • TABLE 19: MEDICAL THERAPEUTICS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
  • TABLE 20: TESTS & COMPONENTS BIOPHOTONICS MARKET, BY TECHNOLOGY, 2013 - 2020 (USD BILLION)
  • TABLE 21: BIOPHOTONICS MARKET, BY REGION, 2013 - 2020 (USD BILLION)
  • TABLE 22: THE AMERICAS BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
  • TABLE 23: THE AMERICAS: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 24: THE AMERICAS: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD BILLION)
  • TABLE 25: THE AMERICAS: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD BILLION)
  • TABLE 26: THE AMERICAS: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 27: THE AMERICAS: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 28: THE AMERICAS: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 29: THE AMERICAS: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 30: THE AMERICAS: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 31: THE AMERICAS: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 32: U.S.: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 33: CANADA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 34: MEXICO: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 35: OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 36: EUROPE: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
  • TABLE 37: EUROPE: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 38: EUROPE: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 39: EUROPE: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 40: EUROPE: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 41: EUROPE: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 42: EUROPE: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 43: EUROPE: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 44: EUROPE: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 45: EUROPE: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 46: U.K.: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 47: GERMANY: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 48: FRANCE: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 49: OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 50: APAC: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
  • TABLE 51: APAC: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 52: APAC: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 53: APAC: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 54: APAC: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 55: APAC: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 56: APAC: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 57: APAC: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 58: APAC: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 59: APAC: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 60: JAPAN: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 61: CHINA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 62: INDIA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 63: OTHERS BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD BILLION)
  • TABLE 64: ROW: BIOPHOTONICS MARKET, BY COUNTRY, 2013 - 2020 (USD BILLION)
  • TABLE 65: ROW BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 66: ROW: BIOPHOTONICS MARKET FOR SEE-THROUGH IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 67: ROW: BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 68: ROW: BIOPHOTONICS MARKET FOR SPECTROMOLECULAR, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 69: ROW: BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 70: ROW: BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 71: ROW: BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 72: ROW: BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 73: ROW: BIOPHOTONICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2013 - 2020 (USD MILLION)
  • TABLE 74: THE MIDDLE EAST: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 75: AFRICA: BIOPHOTONICS MARKET, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 76: BIOPHOTONICS MARKET: KEY PLAYERS, 2014
  • TABLE 77: NEW PRODUCT LAUNCHES
  • TABLE 78: AGREEMENTS, COLLABORATIONS, CONTRACTS, & PARTNERSHIPS
  • TABLE 79: EXPANSIONS AND PATENTS
  • TABLE 80: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: BIOPHOTONICS MARKET: RESEARCH DESIGN
  • FIGURE 2: COUNTRYWISE PERCENTAGE OF AGING POPULATION (2004 VS 2014)
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: BIOPHOTONICS MARKET SNAPSHOT: APPLICATION IN SEE-THROUGH IMAGING ARE EXPECTED TO LEAD THE MARKET
  • FIGURE 7: OTHER END USES SUCH AS BIOMETRICS AND BIOSENSING EXPECTED TO WITNESS THE HIGHEST GROWTH RATE
  • FIGURE 8: GLOBAL BIOPHOTONICS MARKET, BY TECHNOLOGY, 2014
  • FIGURE 9: GLOBAL BIOPHOTONICS MARKET, BY REGION, 2014
  • FIGURE 10: BIOPHOTONICS MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES IN NON-MEDICAL SECTORS
  • FIGURE 11: MEDICAL DIAGNOSTICS SEGMENT TO HOLD THE LARGEST MARKET SHARE IN 2015
  • FIGURE 12: COUNTRIES IN APAC EXPECTED TO WITNESS HIGH GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: OTHER (NON-MEDICAL) SECTORS TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: AMERICAS EXPECTED TO BE THE LEADING MARKET FOR SEE-THROUGH IMAGING TILL 2020
  • FIGURE 15: BIOPHOTONICS MARKET SEGMENTATION
  • FIGURE 16: MARKET, BY APPLICATION
  • FIGURE 17: MARKET, BY TECHNOLOGY
  • FIGURE 18: BIOPHOTONICS MARKET: BY END USE
  • FIGURE 19: BIOPHOTONICS MARKET: BY GEOGRAPHY
  • FIGURE 20: EMERGENCE OF NANOTECHNOLOGY AND TECHNOLOGICAL ADVANCEMENTS ARE THE KEY MARKET DRIVERS
  • FIGURE 21: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
  • FIGURE 22: PERCENTAGE OF WORLD POPULATION, BY COUNTRY, 2014
  • FIGURE 23: VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING R&D AND MANUFACTURING STAGES
  • FIGURE 24: INDUSTRY TRENDS
  • FIGURE 25: PORTER'S FIVE FORCES ANALYSIS: BIOPHOTONICS MARKET
  • FIGURE 26: BIOPHOTONICS MARKET, BY APPLICATION
  • FIGURE 27: BIOPHOTONICS MARKET, BY TECHNOLOGY
  • FIGURE 28: BIOPHOTONICS MARKET, BY END USE
  • FIGURE 29: GEOGRAPHICAL SNAPSHOT: APAC WAS THE FASTEST-GROWING MARKET FOR BIOPHOTONICS, 2014
  • FIGURE 30: THE AMERICAS: MARKET SNAPSHOT
  • FIGURE 31: EUROPEAN MARKET SNAPSHOT
  • FIGURE 32: APAC MARKET SNAPSHOT
  • FIGURE 33: ROW MARKET SNAPSHOT
  • FIGURE 34: COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS THE KEY GROWTH STRATEGY OVER THE LAST FOUR YEARS (2012-2015)
  • FIGURE 35: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES HAS BEEN THE KEY STRATEGY
  • FIGURE 36: GEOGRAPHIC REVENUE MIX OF MAJOR PLAYERS
  • FIGURE 37: AFFYMETRIX, INC. : COMPANY SNAPSHOT
  • FIGURE 38: AFFYMETRIX, INC. : SWOT ANALYSIS
  • FIGURE 39: BECTON, DICKINSON AND COMPANY : COMPANY SNAPSHOT
  • FIGURE 40: BECTON, DICKINSON AND COMPANY : SWOT ANALYSIS
  • FIGURE 41: CARL ZEISS AG : COMPANY SNAPSHOT
  • FIGURE 42: CARL ZEISS AG : SWOT ANALYSIS
  • FIGURE 43: FEI COMPANY: COMPANY SNAPSHOT
  • FIGURE 44: HAMAMATSU PHOTONICS K.K. : COMPANY SNAPSHOT
  • FIGURE 45: HAMAMATSU PHOTONICS K.K. : SWOT ANALYSIS
  • FIGURE 46: LUMENIS LTD. : COMPANY SNAPSHOT
  • FIGURE 47: OLYMPUS CORPORATION : COMPANY SNAPSHOT
  • FIGURE 48: OLYMPUS CORPORATION : SWOT ANALYSIS
  • FIGURE 49: PERKINELMER, INC. : COMPANY SNAPSHOT
  • FIGURE 50: ZECOTEK PHOTONICS INC. : COMPANY SNAPSHOT
Back to Top